阿摩線上測驗 登入

試題詳解

試卷:113年 - 2024 藥學專業題庫(選擇題)101-141#119331 | 科目:藥學專業

試卷資訊

試卷名稱:113年 - 2024 藥學專業題庫(選擇題)101-141#119331

年份:113年

科目:藥學專業

113. LB is a 25 year-old female with AML day 24 s/p 7+3 induction (anthracycline plus cytarabine). Her course has been complicated by culture negative febrile neutropenia with chest x-ray findings (day 20) suggestive of pneumonia. She has received cefepime since day 20. She has been afebrile for 72 hours and has now recovered her neutrophil count. Your leukemia team would like to know when it would be appropriate to discontinue antibacterials. Which of the following is most appropriate response?
(A) LB should stop cefepime since neutropenia has resolved and has been afebrile for at least 2 days
(B) LB has received an adequate course for pneumonia therefore cefepime can be discontinued
(C) LB has received an adequate course for pneumonia and cefepime can be switched to levofloxacin prophylaxis
(D) LB has not received an adequate course for pneumonia but can be de-escalated to oral stepdown therapy to complete her treatment
正確答案:登入後查看

詳解 (共 1 筆)

推薦的詳解#6968220
未解鎖
題目解析 這道題目涉及一位25歲女性患...
(共 1031 字,隱藏中)
前往觀看
0
0